NATURE . COM {
}
Title:
Anticancer drug development: the grand challenges | Nature Reviews Drug Discovery
Description:
Despite vast investment in oncology R&D, the translation of research advances into medicines that substantially improve the treatment of many cancers remains frustratingly slow. What are the key challenges in anticancer drug development, and how might they be addressed?
Website Age:
30 years and 10 months (reg. 1994-08-11).
Matching Content Categories {📚}
- Science
- Education
- Social Networks
Content Management System {📝}
What CMS is nature.com built with?
Custom-built
No common CMS systems were detected on Nature.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of nature.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,058 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Nature.com Make Money? {💸}
Display Ads {🎯}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.comReseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.comHow Much Does Nature.com Make? {💰}
Display Ads {🎯}
$63,100 per month
Our analysis indicates Nature.com generates between $42,042 and $115,617 monthly online from display ads.
Keywords {🔍}
nature, drug, access, article, research, cell, development, cookies, content, open, privacy, discovery, cancer, data, reviews, anticancer, hait, breast, scientific, author, advertising, information, subscribe, challenges, william, oncology, institution, articles, evaluation, imaging, screening, reports, buy, permissions, optional, media, personal, parties, policy, journals, log, journal, comment, april, grand, cite, treatment, manufacture, herpositive, immunotoxin,
Topics {✒️}
nature portfolio permissions reprints privacy policy advertising nature social media anchorage-independent cell growth research advances anticancer drug development springerlink instant access author information authors drug discovery effectiveness personal data data protection permissions author declares competing financial interests privacy cell imaging author explore content subscription content lung cancer european economic area access heterogeneous tissue distribution institutional subscriptions read offered helpful comments senior vice president enaminone-grafted trithiocarbonate accepting optional cookies journals search log manage preferences biological screening content article hait development grand challenges william institution subscribe issue learn institution buy article purchase optional cookies choices article cite essential cookies cookies skip journal publish subscribe sign potential anticancer
Questions {❓}
- What are the key challenges in anticancer drug development, and how might they be addressed?
Schema {🗺️}
WebPage:
mainEntity:
headline:Anticancer drug development: the grand challenges
description:Despite vast investment in oncology R&D, the translation of research advances into medicines that substantially improve the treatment of many cancers remains frustratingly slow. What are the key challenges in anticancer drug development, and how might they be addressed?
datePublished:
dateModified:
pageStart:253
pageEnd:254
sameAs:https://doi.org/10.1038/nrd3144
keywords:
Drug development
Drug regulation
Biomedicine
general
Pharmacology/Toxicology
Biotechnology
Medicinal Chemistry
Molecular Medicine
Cancer Research
image:
isPartOf:
name:Nature Reviews Drug Discovery
issn:
1474-1784
1474-1776
volumeNumber:9
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:William N. Hait
affiliation:
name:William N. Hait, M.D., Ph.D., is Senior Vice President and Worldwide Head at Ortho Biotech Oncology Research and Development, 920 Route 202, Raritan, New Jersey 08869, USA. [email protected]
address:
name:William N. Hait, M.D., Ph.D., is Senior Vice President and Worldwide Head at Ortho Biotech Oncology Research and Development, 920 Route 202, Raritan, New Jersey 08869, USA. [email protected] ,
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Anticancer drug development: the grand challenges
description:Despite vast investment in oncology R&D, the translation of research advances into medicines that substantially improve the treatment of many cancers remains frustratingly slow. What are the key challenges in anticancer drug development, and how might they be addressed?
datePublished:
dateModified:
pageStart:253
pageEnd:254
sameAs:https://doi.org/10.1038/nrd3144
keywords:
Drug development
Drug regulation
Biomedicine
general
Pharmacology/Toxicology
Biotechnology
Medicinal Chemistry
Molecular Medicine
Cancer Research
image:
isPartOf:
name:Nature Reviews Drug Discovery
issn:
1474-1784
1474-1776
volumeNumber:9
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:William N. Hait
affiliation:
name:William N. Hait, M.D., Ph.D., is Senior Vice President and Worldwide Head at Ortho Biotech Oncology Research and Development, 920 Route 202, Raritan, New Jersey 08869, USA. [email protected]
address:
name:William N. Hait, M.D., Ph.D., is Senior Vice President and Worldwide Head at Ortho Biotech Oncology Research and Development, 920 Route 202, Raritan, New Jersey 08869, USA. [email protected] ,
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Nature Reviews Drug Discovery
issn:
1474-1784
1474-1776
volumeNumber:9
Organization:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:William N. Hait, M.D., Ph.D., is Senior Vice President and Worldwide Head at Ortho Biotech Oncology Research and Development, 920 Route 202, Raritan, New Jersey 08869, USA. [email protected]
address:
name:William N. Hait, M.D., Ph.D., is Senior Vice President and Worldwide Head at Ortho Biotech Oncology Research and Development, 920 Route 202, Raritan, New Jersey 08869, USA. [email protected] ,
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:William N. Hait
affiliation:
name:William N. Hait, M.D., Ph.D., is Senior Vice President and Worldwide Head at Ortho Biotech Oncology Research and Development, 920 Route 202, Raritan, New Jersey 08869, USA. [email protected]
address:
name:William N. Hait, M.D., Ph.D., is Senior Vice President and Worldwide Head at Ortho Biotech Oncology Research and Development, 920 Route 202, Raritan, New Jersey 08869, USA. [email protected] ,
type:PostalAddress
type:Organization
PostalAddress:
name:William N. Hait, M.D., Ph.D., is Senior Vice President and Worldwide Head at Ortho Biotech Oncology Research and Development, 920 Route 202, Raritan, New Jersey 08869, USA. [email protected] ,
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(15)
- How much does https://doi.org/10.1186/s12934-023-02115-0 bring in each month?
- What's the revenue for https://doi.org/10.1038/s41598-018-21950-5?
- https://doi.org/10.1038/s41598-017-13025-8's total income per month
- What's the financial outcome of https://link.springer.com/article/10.1038/nrd3144?utm_source=nature&utm_medium=referral&utm_campaign=buyArticle?
- Profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=William%20N.%20Hait
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22William%20N.%20Hait%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- How much does https://s100.copyright.com/AppDispatchServlet?title=Anticancer%20drug%20development%3A%20the%20grand%20challenges&author=William%20N.%20Hait&contentID=10.1038%2Fnrd3144©right=Springer%20Nature%20Limited&publication=1474-1776&publicationDate=2010-04&publisherName=SpringerNature&orderBeanReset=true pull in?
- Earnings of https://citation-needed.springer.com/v2/references/10.1038/nrd3144?format=refman&flavour=citation
- What's the financial gain of https://doi.org/10.1007/s00044-020-02535-2?
- Revenue of https://doi.org/10.1007/s10549-019-05331-8
- How much revenue does https://doi.org/10.1038/nrd.2017.194 bring in?
- https://www.protocols.io/'s revenue stream
- Learn about the earnings of https://www.natureindex.com/
- What's the financial intake of http://www.naturechina.com?
- https://www.natureasia.com/ja-jp's revenue stream
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Prism.js
- Zoom.js
Emails and Hosting {✉️}
Mail Servers:
- mxa-002c5801.gslb.pphosted.com
- mxb-002c5801.gslb.pphosted.com
Name Servers:
- pdns1.ultradns.net
- pdns2.ultradns.net
- pdns3.ultradns.org
- pdns4.ultradns.org
- pdns5.ultradns.info
- pdns6.ultradns.co.uk
CDN Services {📦}
- Crossref